Skip to content

MDMA: all studies

Page 341 of 346: studies 3,401 to 3,410 of 3,454, newest first. Back to the MDMA overview

Research

Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine.

Psychopharmacology April 1995 K M Hegadoren, M T Martin-Iverson, G B Baker

Spontaneous behaviours were assessed in freely moving rats after treatment with equimolar doses of drugs that share a basic amphetamine structure. The drugs used included a psychomotor stimulant [(+)-amphetamine (AMPH)], an hallucinogen [para-methoxyamphetamine (PMA)] and the entactogens 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and...

Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.

European Journal of Pharmacology June 2, 1994 D Marona-Lewicka, D E Nichols 32 citations

The behavioral effects of 5-methoxy-6-methyl-2-aminoindan (MMAI) were examined using the drug discrimination procedure and direct observation for classification of the characteristic syndrome induced by MMAI. The stimulus effects of MMAI were studied in 5 different groups of rats trained to discriminate MMAI (1.71 mg/kg; 8 microM/kg), MDMA (3,4-methylenedioxymethamphetamine; 1.75 mg/kg; 7.6...

Oh I Love Mother, I Love Her Power: Shaker Spirit Possession and the Performance of Desire

Theatre Survey May 1, 1994 Susan McCully 3 citations

Ecstatic religious trance and spirit possession occur across a broad cultural and socioeconomic range, from Pentecostal possession by the Holy Ghost to Ethiopian zar possession cults. Interestingly, this phenomenon is most frequently experienced by young women in their early teens. Folklorists such as Felicitas Goodman postulate that this generational and gendered proclivity for trance...

In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse.

Brain research. Developmental brain research March 18, 1994 K Kramer, E C Azmitia, P M Whitaker-Azmitia

Cortical synaptosomes were prepared from pregnant dams (GD-17) and rat fetuses (ED-17), loaded with [3H]5-HT and assayed to evaluate release mediated by cocaine (COC), fenfluramine (FEN) and 3,4-methylenedioxymethamphetamine (MDMA). COC and FEN elicited a high-affinity (10(-9) M) release response in fetal tissue which was not apparent in the dam. MDMA-induced release was similar in magnitude in...

Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects.

Archives of General Psychiatry February 1, 1994 R J Strassman, C R Qualls

Background: To begin applying basic neuropharmacological hypotheses of hallucinogenic drug actions to humans, we generated dose-response data for intravenously administered dimethyltryptamine fumarate's (DMT) neuroendocrine, cardiovascular, autonomic, and subjective effects in a group of experienced hallucinogen users. Methods: Dimethyltryptamine, an endogenous mammalian hallucinogen and drug...

DOI: 10.1001/archpsyc.1994.03950020009001 (opens in new tab) Cardiovascular system Autonomic nervous system Pupil Humans +15

Nabokov's Cosmic Synchronization and "Something Else"

Nabokov studies 1994 J.B. Sisson 5 citations

Nabokov Studies, 1 (1994), 155-77. J. B. SISSON (Edina, MN, U.S.A.; NABOKOV'S COSMIC SYNCHRONIZATION AND "SOMETHING ELSE" Central to his aesthetic and to an understanding of his work is the concept that Nabokov labels "cosmic synchronization."1 This concept is a formulation of the posited desire of the artist to apprehend the entire universe by an awareness expanding rapidly outward from the...

Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity.

European Journal of Pharmacology November 2, 1993 M D Schechter, T L Gordon 33 citations

Ibogaine is an alkaloid employed for its hallucinatory properties in West Central Africa which has been the subject of alleged efficacy as an aid in the interruption and treatment of chemical dependency. The major sources of the Schedule I agent are: Sigma Chemical Co., the National Institute on Drug Abuse and as NDA International Inc.'s Endabuse. The intent of the present study was to, for the...

Lived fictions: moving from pharmacology to ethnography

Drug and Alcohol Review October 1, 1993 John FitzGerald 4 citations

While positivist science dominates the drug and alcohol research sector, alternative constructivist paradigms of inquiry into drug and alcohol use are also present. The passage of individual researchers through paradigm shifts is often difficult, and rarely documented. Different paradigms of inquiry produce different types of information. The use of the psychoactive drug...

Hyperthermia associated with 3,4‐methylenedioxyethamphetamine (‘Eve’)

Anaesthesia June 1, 1993 B Tehan, R D Hardern, A. Bodenham 48 citations

Summary A patient was admitted with hyperthermia, muscle rigidity, rhabdomyolysis and disseminated intravascular coagulation. He was initially thought to have taken 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), but subsequent toxicology revealed the presence of 3,4‐methylenedioxyethamphetamine (MDEA, ‘Eve’), its sister drug, in his blood. Subsequent in vitro testing for malignant...

Neuroendocrine and cardiovascular effects of MDE in healthy volunteers.

Neuropsychopharmacology May 1993 E Gouzoulis, U Von Bardeleben, A Rupp et al.

The drug 3,4-methylenedioxyethamphetamine ([MDE] also known as "Eve") is a less toxic analog of 3,4-methylenedioxymethamphetamine (also known as "Ecstasy") with similar psychotropic effects in humans. In a double-blind placebo-controlled, cross-over study we administered 140 mg of MDE or placebo orally to eight healthy male volunteers at 1:30 P.M. Serum cortisol, prolactin (PRL), and growth...